Baird Financial Group
EVH icon

Baird Financial Group’s Evolent Health EVH Stock Holding History

Baird Financial Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,412
Closed -$627K – 1293
2018
Q4 		$627K Buy
31,412
+9,299
+42% +$215K ﹤0.01% 914
2018
Q3 		$598K Buy
+22,113
New +$528K ﹤0.01% 993

Other funds holding EVH

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Baird Financial Group's EVH Position: Q1 2019 in Review

Baird Financial Group sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 31,412 shares — an estimated $627K sold.

Baird Financial Group first reported a position in EVH in Q3 2018 and held it in 2 quarters. The position peaked at $627K in Q4 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • Baird Financial Group reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
  • Baird Financial Group sold 31,412 Evolent Health shares in Q1 2019, an estimated $627K.
  • Baird Financial Group first reported a position in Evolent Health in Q3 2018 and held it in 2 quarters.
  • Baird Financial Group's Evolent Health position peaked at $627K in Q4 2018.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Baird Financial Group's 13F filing for Q1 2019, filed 14 May 2019.